SBIR/STTR Research Award
Diagnostic device for detecting biomarkers of early multiorgan injury in saliva
Award amount
$1,000,000Program and phase
SBIR · Phase IIAward year
2017Award details
- Awarding agency
- Department of Defense
- Branch
- Defense Health Agency
- Recipient company
- NANOCOMPOSIX, INC.
- Proposal award date
- 2017-09-25
- Contract end date
- 2020-02-24
- UEI
- EVQMBF7KC8P3
- Solicitation number
- 2016.1
- Topic code
- DHP16-006
Research abstract
Combat soldiers are exposed to vast numbers of dangerous chemicals with potentially adverse health outcomes. This SBIR proposal aims to develop a new class of saliva based diagnostic assays that will measure the bodys response to toxic chemical exposure with a panel of clinically validated biomarkers that are indicative of organ injury. The tests will leverage the proven functionality of lateral flow diagnostic devices with novel nanoparticles and extraction formats that have the potential to increase lateral flow assay sensitivity by up to 3 orders of magnitude over the current state of the art. The developed diagnostic will be rapid, inexpensive and accurate. A smart phone based reader compatible with equipment already carried by soldiers will quantify the signal from each of the channels of the multiplexed diagnostic and interpret the results.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Obscurant Material Drying Processes
- THE OBJECTIVE OF THIS CONTRACT IS TO DESIGN AND SYNTHESIS A NEW PLGA BASED NANOPARTICLE WITH NANOPARTICLE WITH OPTIMAL PROTEIN-ADJUVANT FORMULATION CO
- A point of care test for TB antibiotic concentration in blood
- Rapid diagnostic to determine CMV serological status
- New Carriers Used as Adjuvants for Controlled HIV Immunogen Delivery into Targeted Antigen Presenting Cells
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Diagnostic Device for Detecting Biomarkers of Early Multiorgan Injury in Saliva
- Cell Phone-based Early Detection of Multi-Organ Injury Biomarkers in Saliva
- Nanowire Array Diagnostics for Early Multiorgan Injury in Saliva
- Cell-phone-based Early Detection of Multi-organ Injury Biomarkers in Saliva
- Diagnostic device for detecting biomarkers of early multiorgan injury in saliva
Research funding history
50 SBIR/STTR records share this UEI (2005–2020). Reported award amounts total $19,180,547. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Defense, Department of Health and Human Services, National Science Foundation, National Aeronautics and Space Administration